Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-10-12
Summary
In order to develop a test to diagnose overactive bladder from urine, it is essential that this test is at least as accurate as the tools that clinicians currently use. As such, this study will compare the performance of the device in development to the performance of existing methods.
Conditions
- Overactive Bladder
- Overactive Bladder Syndrome
- Detrusor Overactivity
Interventions
- DIAGNOSTIC_TEST
-
Urodynamics aka filling cystometry
Participants will be undergoing a routine diagnostic test to characterise bladder function and volume
Sponsors & Collaborators
-
South Tees Hospitals NHS Foundation Trust
collaborator OTHER -
Teesside University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2023-10-31
- Completion
- 2023-11-30
More Related Trials
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
NCT03572231 ·Status: COMPLETED
-
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
NCT01729819 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms
NCT04999657 ·Status: COMPLETED ·Phase: NA
-
TPTNS: Home vs Hospital Treatment for Overactive Bladder
NCT03727711 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)
NCT00768521 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder
NCT00137397 ·Status: COMPLETED ·Phase: PHASE4
-
Bladder Diary for Diagnosing Bladder Oversensitivity
NCT04981015 ·Status: COMPLETED
-
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
NCT02386072 ·Status: COMPLETED
-
Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome
NCT03695822 ·Status: WITHDRAWN ·Phase: PHASE4
-
Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.
NCT01282840 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder.
NCT04483817 ·Status: UNKNOWN ·Phase: NA
-
Fall Prevention in Older Adults With OAB
NCT03946124 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
NCT03810027 ·Status: COMPLETED
-
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
NCT05157295 ·Status: UNKNOWN ·Phase: PHASE4
-
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
NCT01175382 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial
NCT05188742 ·Status: UNKNOWN ·Phase: PHASE4
-
Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug
NCT01627145 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
NCT05719285 ·Status: COMPLETED ·Phase: PHASE4
-
InSite for Over Active Bladder
NCT00547378 ·Status: COMPLETED ·Phase: PHASE4
-
Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
NCT01435083 ·Status: COMPLETED ·Phase: PHASE4
-
Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study
NCT05946902 ·Status: UNKNOWN ·Phase: PHASE4